Menu Menu
 

All Posts

Multi-ethnic study of atherosclerosis: objectives and design.

Published: February 27th, 2015

Cohort Profile: LifeLines, a three-generation cohort study and biobank.

Published: February 27th, 2015

Universal risk factors for multifactorial diseases: LifeLines: a three-generation population-based study.

Published: February 27th, 2015

KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST).

Published: February 27th, 2015

beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.

Published: February 27th, 2015

Promoter polymorphisms in ACE (angiotensin I-converting enzyme) associated with clinical outcomes in hypertension.

Published: February 27th, 2015

Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES).

Published: February 27th, 2015

Genetic and pharmacogenetic associations between NOS3 polymorphisms, blood pressure, and cardiovascular events in hypertension.

Published: February 27th, 2015

CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response.

Published: February 27th, 2015

Genetic variation in the beta2 subunit of the voltage-gated calcium channel and pharmacogenetic association with adverse cardiovascular outcomes in the INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES).

Published: February 27th, 2015